SEC Comment Letter for Cellectis S.A. (CLLS) (CIK 0001627281) (CLLS) — Apr 7, 2017
Cellectis S.A. (CLLS) (CIK 0001627281)
Date: April 7, 2017 · CIK: 0001627281 · Accession: 0000000000-17-012024
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217086
Letter
Mail Stop 4546 April 7 , 2017 André Choulika Chief Executive Officer Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France
Re: Cellectis S.A. Registration Statement on Form F-3 Filed March 31, 2017 File No. 333-217086
Dear Mr. Choulika :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at (202) 551 -3798 with any questions.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4546 April 7 , 2017 André Choulika Chief Executive Officer Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France Re: Cellectis S.A. Registration Statement on Form F-3 Filed March 31, 2017 File No. 333-217086 Dear Mr. Choulika : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at (202) 551 -3798 with any questions. Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Boris Dolgonos Jones Day